Post-transplantation bone disease: The role of immunosuppressive agents and the skeleton

Journal of Bone and Mineral Research

Volumn 11, Issue 1, 1996, Pages 1-7

  Epstein, Sol ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; AZATHIOPRINE; BREQUINAR; CYCLOSPORIN A; CYCLOSPORIN G; GLUCOCORTICOID; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; LEFLUNOMIDE; METHOTREXATE; MIZORIBINE; RAPAMYCIN; TACROLIMUS; TUMOR NECROSIS FACTOR;

ALOPECIA; BONE ATROPHY; DIARRHEA; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; GONAD FUNCTION; HIRSUTISM; HUMAN; HYPERGLYCEMIA; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; ORGAN TRANSPLANTATION; OSTEOPENIA; PATHOGENESIS; REVIEW; VITAMIN BLOOD LEVEL; VITAMIN METABOLISM;

EID: 0030067972     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.5650110102     Document Type: Review

References (74)

1. Lukert BP, Raisz LG 1990 Glucocorticoid induced osteoporosis pathogenesis and management. Ann Intern Med 112:352-364.
2. Reid IR, Schooler BA, Stewart AW 1990 Prevention of glucocorticoid induced osteoporodis. J Bone Miner Res 5:619-623.
3. Dempster DW 1989 Perspectives: Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res 4:137-141.
4. 6 and IFN gamma. J Immunol 146:3523-3527.
5. Bateman A, Singh A, Kral T, Solomon S 1989 The immune hypothalamic-pituitary adrenal axis. Endocrinol Rev 10:92-112.
6. Mann G. Jacobs T, Buchinsky F, Armstrong EC, Li M, Ke H. Ma Y, Jee W, Epstein S 1994 Interferon-γ causes loss of bone volume in vivo and fails to ameliorate cyclosporin A induced osteopenia. Endocrinology 135:1077-1083.
7. Movsowitz C, Schlosberg M, Epstein S, Ismail F, Fallon M 1990 Combined treatment with cyclosporin A and cortisone acetate minimize the adverse bone effects of either agent alone. J Orthoped Res 8:635-641.
8. Turner RT, Hannon KS, Greene VS, Bell NH 1995 Prednisone inhibits formation of cortical bone in sham operated and ovariectomized female rats. Calcif Tissue Int 56:311-315.
9. Kelly PJ, Sambrook PN, Eisman JA 1989 Potential protection by cyclosporin against glucocorticoids effects on bone. Lancet ii:1388.
10. Kahan BD 1989 Cyclosporine. New Engl J Med 321:1725-1738.
11. Suthanthiran M, Strom TB 1994 Renal transplantation. New Engl J Med 331:365-376.
12. Schreiber SL 1992 Immunophilin sensitive protein phosphatase action in cell signaling pathway. Cell 70:365-368.
13. Li B, Sehajpal PK. Khanna A. et al 1991 Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of a novel competitor DNA construct in the quantitative polymerase chain reaction. J Exp Med 174:1259-1262.
14. Luke RG 1994 New issues in therapy after renal transplantation. New Engl J Med 331:393-394.
15. Klaushofer K, Hoffman O, Stewart P, Metal M, Koller K, Peterlik M, Stern P 1987 Cyclosporin A effects on resorption in neonatal mouse calvaria. J Pharmacol Exp Ther 243:580-584.
16. Skjodt H, Crawford A, Elford PR, Ihrie E, Wood D, Russell RGG 1985 Cyclosporin A modulates interleukin activity on bone in vitro. Br J Rheumatol 24:165-169.
17. Stewart PJ, Green OC, Stem PH 1986 Cyclosporin A inhibits calcemic hormone induced bone resorption in vitro. J Bone Miner Res 2:285-291.
18. Epstein S 1991 Cyclosporine friend or foe? Calcif Tissue Int 49:232-234.
19. Keown PA, Shiller CR 1987 Cyclosporin a double-edged sword. Hosp Prac 22:207-220.
20. Chowdhury MH, Shen V, Dempster DW 1991 Effects of cyclosporine A on chick osteoclasts in vitro. Calcif Tissue Int 49:275-279.
21. Pilchmayr R 1995 European mycophenolate mofetil cooperative study group. Placebo controlled study of mycophenolate mofetil combined with Cyclosporin and corticosteroids for prevention of acute rejection. Lancet 345:1321-1325.
22. Hollander AMJ, Van Saase JLCM, Kootle Amn, Van Dorp WT, van Bockel HJ, Van Es LA, van de Woude FJ 1995 Beneficial effects of conversion from dyclosporin to azathioprine after kidney transplantation. Lancet 345:610-614.
23. US Multicenter FK506 liver study group 1994 Comparison of tacrolimus FK506 and cyclosporine for immunosuppression in liver transplantation. New Engl J Med 331:1110-1115.
24. McDonald J, Dunstan CR, Dilworth P, Sherbon K, Ross Shell AG. Evans R. McCaughan GW 1991 Bone loss after liver transplantation. Hepatology 14:613-619.
25. Hawkins FG, Leon M, Lopez MB, Valer NA, Larrodera L, Garcia Garcia L, Loinaz C, Moreno Gonzales L1994 Bone loss and turnover in patients with liver transplantation. Hepato Gastroenterol 41:158-161.
26. Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S 1988 Cyclosporin A in vivo produces severe osteopenia in the rat. Effect of dose and duration of administration. Endocrinology 123:2571-2577.
27. Stein B, Takizawa M, Katz I, Joffe I, Berlin J, Fallon M, Epstein S 1991 Salmon calcitonin prevents cyclosporin A induced high turnover bone loss. Endocrinology 129:92-98.
28. Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S 1990 The bisphosphonate 2-PEBP inhibits cyclosporin A induced high turnover osteopenia in the rat. J Clin Med 115:62-68.
29. 3 modifies cyclosporine induced bone loss. Calcif Tissue Int 47:152-157.
30. 2 alleviates cyclosporin A induced bone loss in the rat. J Bone Miner Res 7:1191-1200.
31. Bryer H, Isserow, I, Armstrong E, Mann G, Rucinski B, Buchinsky F, Romero D, Epstein S 1995 Azathioprine alone is bone sparing and does not alter cyclosporin A induced osteopenia in the rat J Bone Miner Res 10:132-138.
32. Sambrook PN, Kelly PJ, Keogh A, Macdonald P, Spratt P, Freund J, Eisman JA 1994 Bone loss after cardiac transplantation; a prospective study. J Heart Lung Transplant 13:116-121.
33. 3 in the rat and mouse. Endocrinology 128:1369-1373.
34. Schlosberg M, Movsowitz C, Epstein S, Ismail F, Fallon MD, Thomas S 1989 The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat. Endocrinology 124:2179-2184.
35. Movsowitz C, Epstein S, Ismail F, Fallon M, Thomas S 1989 Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption. J Bone Miner Res 4:393-398.
36. Katz I, Li M, Joffe I, Stein B, Jacobs T, Liang X, Ke H, Jee W, Epstein S 1994 Influence of age on cyclosporin A induced alterations in bone mineral metabolism in the rat in vivo. J Bone Miner Res 9:59-67.
37. del Pozo E, Lippune K, Ruch W, Casez J, Dayne T, Mackenzie A, Jaeger P 1995 Different effects of cyclosporin A on bone remodelling in young and adult rats. Bone 16:271s-275s.
38. Huang CC, Skingle S, Greer S, Alexander F, Compston J 1995 Post-transplantation osteoporosis: evidence for parathyroid hormone induced bone loss. Calcif Tissue Int 5:278.
39. Ramirez G. Navarate J, Bittle P, Ayers Chastain C, Dean SE 1991 Cyclosporine induced alteration in the hypothalamic hypophysial gonadal axis in transplant patients. Nephron 58:27-32.
40. Krueger B, Trakshel GM, Sluss PM, Maines MD 1991 Cyclosporine-mediated depression of luteinizing hormone receptors and heme biosynthesis in rat testes: a possible mechanism for decrease in serum testosterone. Endocrinology 129:2647-2653.
41. Sambrook P, Kelly P, Fontana D, Nguyen T, Keogh A, Macdonald D, Spratt D, Freund J, Elsman J 1994 Mechanism of rapid bone loss following cardiac transplantation. Osteoporosis Int 4:273-276.
42. Bertolini DR, Badger A, High W 1993 Effect of immunomodulators on bone in the rapidly growing rat. J Bone Miner Res 8:S315.
43. Orcel P, Bielakoff J, Modrowski D, Mravet L, DeVenejoul M 1989 Cyclosporin A induces in vivo inhibition of resorption and stimulation of formation in rat bone. J Bone Miner Res 4:387-391.
44. Klein L, Shaffer T, Wolfe M 1994 Cyclosporin does not affect the absolute rate of cortical bone at the organ level in the growing rat. Calcif Tissue Int 55:295-301.
45. Nishiyama K, Okinaga A 1993 Osteonecrosis after renal transplantation in children. Clin Orthop Rel Res 295:168-171.
46. Ito M, Hirata N,. Fukuoka M, Azuma Y, Sato H, Chokki M, Sugimoto I, Ohta T, Kiyoki M 1995 The continuous treatment with salmon calcitonin prevents bone loss induced by cyclosporine in rats. Bone 16:209S.
47. Buchinsky F, Rucinski B, Mann G, Isserow J, Bryer H, Armstrong E, Epstein S 1994 The influence of T lymphocytes on bone mineral metabolism in the cyclosporin A (CsA) treated rat. IX International Vitamin D Workshop. May 1994, Orlando, Florida.
48. Marshall, I, Isserow J, Buchinsky P, Paynton B, Epstein S 1995 Expression of interleukin 1 and interleukin 6 in bone from normal and cyclosporin A treated rats. XI International conference on calcium regulating hormones. Melbourne, Australia, February, 1995.
49. Joffe I, Katz I, Jacob T, Stein B, Takizawa M, Lin C, Berlin J, Epstein S 1992 17 Beta Estradiol prevents osteopenia in the oophorectomized rat treated with Cyclosporin A. Endocrinology 130:1578-1586.
50. Sass DA, Bowman AR, Marshall I. Liss T, Yuan Z, Ma YF, Jee WSS, Epstein S 1995 The bisphosphonate, alendronate, reverses cyclosporine-induced osteopenia in the aged rat. Am Soc Bone Miner Res, Baltimore, Maryland.
51. Bowman AR, Sass DA, Marshall I, Liang H, Ma F, Jee WSS, Epstein S 1995 Raloxifene analog (LY117018HCL) ameliorates cyclosporin A induced osteopenia in oophorectomzied rats. Amer Soc. Bone Miner Res, Baltimore. Maryland.
52. Mann G, Sass D, Chen H, Buchinsky F, Bryer H, Ma Y, Jee W, Epstein S 1996 Short term systemic insulin like growth factor is unable to ameliorate cyclosporin A induced osteoporosis (submitted).
53. Bagi CM, DeLeon E, Brommage R, Rosen D 1995 Sommers A. Treatment of ovariectomized rats with the complex of rhIGF-1/IGFB-3 increases corticai and cancellous bone mass and improves structure in the femoral neck. Calcif Tissue Int 57:40-46.
54. Pak CYC, Sakhaee K, Adams-Huet B, Piziak V, Peterson RD, Poindexter JR 1995 Treatment of postmenopausal osteoporosis with slow release sodium fluoride. Ann Intern Med 123: 401-408.
55. Cvetkovic M, Mann G, Romero D, Liang X, Ma Y, Jee W, Epstein S 1994 Deleterious effects of long term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. Transplantation 57:1231-1237.
56. Kino T, Hatanaka H, Miyata S 1987 FK506 a novel immuno-suppressant isolated from Streptomyces: Immunosuppressive effect of FK506 in vitro. J Antibiot Tokyo 40:1256-1265.
57. Hollander A, van Saase J, Kovlte A, Nan Dan W, van Bockel H, Van Es L, Vanderwoude F 1995 Beneficial effects of conversion from cyclosporine to azathioprine after kidney transplantation. Lancet 345:610-614.
58. Rajab AH, Frech RS, Vietti TJ 1970 Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission. Cancer 25:580-585.
59. Atkinson S, Fraher L, Gundberg C, Andrew M, Tai M, Barr R 1989 Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia. J Pediatr 114:793-800.
60. May K, Sterling G, McDermott M, Huffer W 1994 The effect of low dose methotrexate on bone metabolism and histomorphometry in rats. Arthritis Rheumat 37:201-206.
61. Wheeler DL, Vandergrend R, Wronski T, Miller G, Keith E, Graves J 1995 The short and long term effects of methotrexate on the rat skeleton. Bone 16:215-221.
62. Dumont F, Staruch M, Koprak S, Melino M, Sigal N 1990 Distinct mechanisms of suppression of murine T cell activation by the related macrolides. FKSO6 and Rapamycin. J Immunol 144:251-258.
63. cdc2 expression and arrests T lymphocytes proliferation at C-1/S transition. Ann NY Acad Sci 696:31-37.
64. Wicker L, Boltz R, Matt V, Nichols E, Peterson L, Sigal N 1990 Suppression of B cell activation by cyclosporin A, FK506 and rapamycin. J Immunol 20:2277-2783.
65. Romero D, Buchinsky F, Rucinski B, Cvetkovic M, Bryer H, Liang X, Ma Y, Jee W, Epstein S 1995 Rapamycin: A bone sparing immunosuppressant? J Bone Miner Res 10:760-767.
66. Rich GM, Mudge G, Laffel G, LeBoff M 1992 Cyclosporin A and prednisone associated osteoporosis in heart transplant recipients. J Heart Lung Transplant 11:950-958.
67. Shane E, Rivas M, Silverberg S, Kim T, Staron R, Bilezikian J 1993 Osteoporosis after cardiac transplantation. Am J Med 94:257-264.
68. Thiebaud D, Krieg M, Gillard D. Goy J, Buckhardt P 1994 Cyclosporine maintains high bone turnover with cortical bone loss after heart transplantation. J Bone Miner Res 9:S387.
69. Valero M, Loinaz C, Larrodera L, Leon M, Moreno E, Hawkins F 1995 Calcitonin and bisphosphonates treatment in bone loss after liver transplantation. Calcif Tiss Int 57: 15-19.
70. Eastell R, Dickson E, Hodgson S, Wiesner R, Porayko M, Wahne H, Cedel SL, Riggs B, Krom R 1991 Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 14:296-300.
71. Julian B, Laskow D, Dubovsky J, Dubovsky E, Curtis J, Quarles L 1991 Rapid loss of vertebral bone density after renal transplantation. N Engl J Med 325:544-550.
72. Horber F, Casez P, Steger U, Czerniack A, Montandon A, Jaeger PH 1994 Changes in bone mass early after kidney transplantation. J Bone Miner Res 9:1-9.
73. Bourbigot B, Moal MC, Cleder J 1988 Bone histology in renal transplant patients receiving cyclosporin. Lancet 1:1048-1049.
74. Aubia J, Masramon J, Serrano S 1988 Bone histology in renal patients receiving cyclosporin. Lancet 1:1048.